AzTrials
AzTrials

Frail Elderly SyndromeNCT03689322

Effects of WBV Associated With IMT on Inflammatory Markers, Body Composition, Muscle Strength and Thickness

A study testing WBV + IMT in people with Frail Elderly Syndrome, run by Universidade Federal de Pernambuco at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aging generates immune, muscular and functional changes. In the pre-frail elderly these changes may be increased and, therefore, preventive interventions are indicated to minimize the consequences of sarcopenia in this population. Read more about this study

Who is it for?
Ages 60 to 80 years, women onlyHealthy volunteers can take part
Conditions the study is for
Frail Elderly Syndrome
What is being tested?
WBV + IMT
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
42 participants
Where
1 siteBrazil
Study dates
1 Oct 2018to 30 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Elderly individuals able to walk without assistance
  • Good understanding to carry out the proposed tests, evaluated through the Mini Mental State Examination (MMSE).

Who cannot join

  • Contraindication or difficulty to perform evaluation procedures
  • Users of medications that interfere with the cardiovascular and / or muscular system
  • Smokers
  • Neuromuscular or degenerative diseases
  • Pulmonary comorbidities
  • Heart diseases
  • Labyrinthitis.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Federal University of Pernambuco

    Recife, Pernambuco

Other trials in Brazil

About this study

Official title: Effects of Whole Body Vibration Associated With the Inspiratory Muscle Training Program on Inflammatory Markers, Body Composition, Muscle Strength and Thickness

Aging generates immune, muscular and functional changes. In the pre-frail elderly these changes may be increased and, therefore, preventive interventions are indicated to minimize the consequences of sarcopenia in this population. This study aims to evaluate the effects of a whole body vibration training associated with the training of inspiratory muscles on the inflammatory, muscular and body composition outcomes in pre-frail elderly women.

Being tested
WBV + IMT, WBV + IMTsham, WBVsham + IMTsham
Keywords
aging, whole body vibration, respiratory muscle training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WBV + IMTOther

    The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training will be performed through a device that provides inspiratory resistance.

  • WBV + IMTshamOther

    The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training sham will be performed through a device without inspiratory resistance.

  • WBVsham + IMTshamOther

    Whole body vibration training will be performed through a vibrating platform coupled to a device that generates non-therapeutic low frequency vibration. The simulation of inspiratory muscle training will be performed through a device with no inspiratory resistance.

Study groups in NCT03689322
Study groupRoleWhat they receive
WBV + IMTExperimentalWhole body vibration training associated with respiratory muscle training (WBV + IMT)
Receives: Other: WBV + IMT
WBV + IMTshamActive comparatorWhole body vibration training associated with respiratory muscle training sham (WBV + IMTsham)
Receives: Other: WBV + IMTsham
WBVsham + IMTshamSham comparatorWhole body vibration training sham associated with respiratory muscle training sham (WBVsham + IMTsham)
Receives: Other: WBVsham + IMTsham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory Muscle Strength and Resistance

    Maximum Inspiratory and Expiratory Pressure will be evaluated through manovacuometer

    Measured: Change from Baseline respiratory muscle strength and resistance at 3 months

Secondary outcomes (5)
  1. Thickness of the quadriceps muscle

    Ultrasound will be used to assess the thickness of the quadriceps muscle according to the pre-established protocol.

    Measured: Change from Baseline thickness of the quadriceps muscle at 3 months

  2. Diaphragmatic thickness

    Ultrasound will to use to evaluate diaphragm thickness non-invasively in the zone of apposition during tidal breathing and with changes in lung volume.

    Measured: Change from Baseline diaphragmatic thickness at 3 months

  3. Diaphragmatic mobility

    During respiration to total lung capacity, measurement of the diaphragmatic excursion will be assessed by ultrasonography.

    Measured: Change from Baseline diaphragmatic mobility at 3 months

  4. Body Composition

    Body composition will be evaluated through bioimpedance balance

    Measured: Change from Baseline body composition at 3 months

  5. Inflammatory markers

    Blood concentration of Interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and brain-derived neurotrophic factor (BDNF) will be assessed through blood plasma sample.

    Measured: Change from Baseline inflammatory markers at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2018
  2. Study start1 Oct 2018
  3. Primary completion30 May 2019
  4. Study completion30 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03689322
Sponsor's protocol ID
WBV on inflammatory biomarkers
Status last verified
Sep 2019
First submitted
25 Sep 2018
Last updated
25 Sep 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing WBV + IMT in people with Frail Elderly Syndrome, run by Universidade Federal de Pernambuco at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory Muscle Strength and Resistance (time frame: Change from Baseline respiratory muscle strength and resistance at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in